We are live on ! Find out more
CCRN

Cross Country Healthcare

Delisted

CCRN was delisted on the 20th of July, 2026.

193 hedge funds and large institutions have $1.04B invested in Cross Country Healthcare in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 51 increasing their positions, 83 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,187% more call options, than puts

Call options by funds: $12.1M | Put options by funds: $943K

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

24% more capital invested

Capital invested by funds: $842M → $1.04B (+$198M)

0.68% more ownership

Funds ownership: 102.51%103.18% (+0.68%)

4% less funds holding

Funds holding: 200193 (-7)

14% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 36

39% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 83

Holders
193
Holders Change
-7
Holders Change %
-3.5%
% of All Funds
3.02%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
31
Increased
51
Reduced
83
Closed
36
Calls
$12.1M
Puts
$943K
Net Calls
+$11.2M
Net Calls Change
+$9.62M

CCRN Hedge Fund Activity: Q2 2023 in Review

193 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Cross Country Healthcare (CCRN) for Q2 2023, worth a combined $1.04B — up 24% from $842M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of CCRN and 31 opened new positions — a net loss of 5 holders — while 83 trimmed existing stakes and 51 added.

The largest buyer was Citadel Advisors, adding an estimated $16.5M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $16M.

  • 193 institutional investors held Cross Country Healthcare (CCRN) as of Q2 2023, down from 200 in Q1 2023.
  • Funds reported $1.04B of Cross Country Healthcare stock for Q2 2023, up 24% quarter-over-quarter.
  • 31 funds opened new Cross Country Healthcare positions in Q2 2023 and 36 closed out, a net change of -5 holders.
  • The largest Cross Country Healthcare buyer in Q2 2023 was Citadel Advisors, an estimated $16.5M added.
  • The largest Cross Country Healthcare seller in Q2 2023 was Jacobs Levy Equity Management, an estimated $16M sold.

Based on aggregated 13F filings for Q2 2023.